STRATA Skin Sciences (SSKN) EBITDA Margin Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,695.00 |
| Sep 30, 2025 | 376.00 |
| Jun 30, 2025 | 993.00 |
| Mar 31, 2025 | -1,094.00 |
| Dec 31, 2024 | -6,864.00 |
| Sep 30, 2024 | -850.00 |
| Jun 30, 2024 | 706.00 |
| Mar 31, 2024 | -2,616.00 |
| Dec 31, 2023 | -6,942.00 |
| Sep 30, 2023 | -216.00 |
| Jun 30, 2023 | -728.00 |
| Mar 31, 2023 | -894.00 |
| Dec 31, 2022 | 5,252.00 |
| Sep 30, 2022 | 17,501.00 |
| Jun 30, 2022 | -2,054.00 |
| Mar 31, 2022 | -2,411.00 |
| Dec 31, 2021 | 483.00 |
| Sep 30, 2021 | 1,341.00 |
| Jun 30, 2021 | -1,896.00 |
| Mar 31, 2021 | -1,299.00 |
| Dec 31, 2020 | 111.00 |
| Sep 30, 2020 | 12,573.00 |
| Jun 30, 2020 | 124,405.00 |
| Mar 31, 2020 | 446,986.00 |
| Dec 31, 2019 | 173,272.00 |
| Sep 30, 2019 | 103,980.00 |
| Jun 30, 2019 | -29,139.00 |
| Mar 31, 2019 | 483,014.00 |
| Dec 31, 2018 | 318,432.00 |
| Sep 30, 2018 | 575,737.00 |
| Jun 30, 2018 | 485,372.00 |
| Mar 31, 2018 | 447,539.00 |
| Dec 31, 2017 | 494,413.00 |
| Sep 30, 2017 | 758,164.00 |
| Jun 30, 2017 | 725,961.00 |
| Mar 31, 2017 | 5.13 Mn |